Back to search

Article

Analysis of a simple disk diffusion method to evaluate Ceftazidime-avibactam/Aztreonam combination synergism against NDM clinical isolates.

2025-05-02

Abstract excerpt

Treatment with Ceftazidime avibactam/Aztreonam combination may offer a clinical benefit in patients suffering with Multidrug resistant bacterial infection. The present study aimed to detect genes encoding carbapenem resistance in clinical strains and to evaluate the efficacy of ceftazidime-avibactam/aztreonam combination against carbapenemase co-producers. A Cross-sectional research was done on 62 Carbapenem resis...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
693f0375-d70f-5bff-a3cf-2d9753cea5bd
DOI
10.1099/acmi.0.001049.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Analysis of a simple disk diffusion method to evaluate Ceftazidime-avibactam/Aztreonam combination synergism against NDM clinical isolates.DOI 10.1099/acmi.0.001049.v1
Analysis of a simple disk diffusion method to evaluate Ceftazidime-avibactam/Aztreonam combination synergism against NDM clinical isolates.Semantic proximity
Ceftazidime-Avibactam plus aztreonam synergistic combination tested against carbapenem-resistant Enterobacterales characterized phenotypically and genotypically: a glimmer of hopeSemantic proximity
Investigation of in-vitro efficacy of antibiotic combinations and presence of carbapenemases in multidrug-resistant Klebsiella pneumoniae isolatesSemantic proximity
Assessment of the activity and mechanisms of resistance to cefiderocol and combinations of β-lactams and the novel β-lactamase inhibitors avibactam, taniborbactam, zidebactam, nacubactam, xeruborbactam, and ANT3310 in emerging double-carbapenemase-producing EnterobacteralesSemantic proximity
Ceftazidime-avibactam resistance determination in carbapenem-resistant Klebsiella pneumoniae infections before its use in practiceSemantic proximity
Aztreonam-avibactam synergy, a validation and comparison of diagnostic toolsSemantic proximity
Evaluation of two gradient diffusion tests to determine susceptibility to aztreonam and ceftazidime–avibactam in combinationSemantic proximity
Comparative Evaluation of Phenotypic Methods for Testing Ceftazidime-Avibactam and Aztreonam Synergy in Carbapenem-Resistant Enterobacterales from a Tertiary Care Center in Eastern IndiaSemantic proximity
Synergistic Activity of Cefiderocol in Combination with Avibactam, Sulbactam or Tazobactam against Carbapenem-Resistant Gram-Negative BacteriaSemantic proximity
Improved Blue Carba test and Carba NP test for detection and classification of major Class A and B carbapenemases, including dual producers, among Gram-negative bacilliSemantic proximity
Aztreonam Combinations with Avibactam, Relebactam, and Vaborbactam as Treatment for New Delhi Metallo-β-Lactamase-Producing Enterobacterales Infections—In Vitro Susceptibility TestingSemantic proximity
New Carbapenemase Inhibitors: Clearing the Way for the β-LactamsSemantic proximity
Select a neighboring publication to make it the new centre.